The 5th annual regulatory conference on ATMPs, organised by EBE with the support of the European Medicines Agency (EMA) took place on 16 December 2016, in London, UK. The event saw a packed house - the greatest participation so far.
The key focus of the discussions was on gene therapy and investigational ATMPs.
The summary report from the meeting has just become available, and like agenda and presentations, will be uploaded both on our website and on the EMA website. As a service to our members, a full report on the meeting will be made available on our members’ only website.
Agenda and presentations are available here.
Read here the conference summary report. The full report is available exclusively to the EBE members on the EBE members only area.